SHULMAN STEPHEN 4
4 · GALECTIN THERAPEUTICS INC · Filed Dec 18, 2017
Insider Transaction Report
Form 4
SHULMAN STEPHEN
Director
Transactions
- Award
Stock option (right to buy)
2017-12-14+46,875→ 46,875 totalExercise: $2.39Exp: 2027-12-14→ Common stock (46,875 underlying)
Footnotes (1)
- [F1]The options vest 100% on December 14, 2018.